tirzepatide cardiovascular risk compared with semaglutide and 10-year disease reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial UC Irvine researchers project cardiac
Description
Kadowaki et al., 2022
Darsalia V, Ortster H, Olverling A, Darlf E, Wolbert P, Nystrm T, et al
Burning those stores of fat and burning the fat you consume is the second line
Referral potential: Map primary care practices, endocrinologists, and bariatric surgeons who might refer patients to a medical weight loss program
In that sense, the efficacy of SANA in humans needs to be further studied in a phase 2 clinical trial, with longer treatment, increased sample number, and extended measurements to validate its efficacy and mechanism of action
Q: Will I regain weight if I stop taking these medications
